Search

 
News

Guidelines on Antiviral treatment for children under 1 year of age - 24/8/2009

Guidelines on Antiviral treatment for children under 1 year of age


The European Medicines Agency (EMEA) recommends that children below 1 year of age, if confirmed positive, are treated with Tamiflu (oseltamivir). The appropriate dosage to treat children less than 1 year of age is 2mg per kg twice daily for 5 days. Children below 1 year of age should be treated under medical supervision. It is recommended that at least children below 3 months of age are preferably treated under medical supervision in hospital.

Based on this recommendation the following protocol has been set up by the Department of Paediatrics of Mater Dei in collaboration with the Infectious Disease Prevention and Control Unit (IDCU) for the management of antiviral treatment of confirmed cases of children under 1 year of age:


1. Children under (<) 3 months requiring Tamiflu are admitted and treated in hospital.

2. Those above ≥3 months - <12 months are treated at home unless they require admission or closer supervision.

3. Those treated at home need to be monitored by their family doctor or paediatrician during the 5 days of treatment.

4. Parents need to be made aware to look out for any of the following side affects that could occur while taking Tamiflu syrup:

untoward vomiting, severe diarrhoea
altered breathing
swelling (especially face and lips)
rash
jaundice
marked lethargy


If any of the following occur then parents should be advised to immediately consult the doctor or paediatrician.

Dr. Charmaine Gauci





 
 
Developed by Alert Communications|  Disclaimer  |  Copyright  |  Privacy Policy
 
Home Home Home